PDCD1LG2 and neoplasm: Similarly, PD-1 is another immune checkpoint receptor that is often expressed on the surface of tumor-infiltrating lymphocytes, while its ligands PD-L1 and PD-L2 are highly expressed on tumors; the interaction of PD-1 with PD-L1/PD-L2 can lead to a diminished immune response (25).